首页> 美国卫生研究院文献>PLoS Clinical Trials >Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D3, 1,25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3
【2h】

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D3, 1,25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3

机译:主要人类成骨细胞对25-羟基维生素D3、1,25-二羟基维生素D3和24R,25-二羟基维生素D3的响应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The most biologically active metabolite 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) has well known direct effects on osteoblast growth and differentiation in vitro. The precursor 25-hydroxyvitamin D3 (25(OH)D3) can affect osteoblast function via conversion to 1,25(OH)2D3, however, it is largely unknown whether 25(OH)D3 can affect primary osteoblast function on its own. Furthermore, 25(OH)D3 is not only converted to 1,25(OH)2D3, but also to 24R,25-dihydroxyvitamin D3 (24R,25(OH)2D3) which may have bioactivity as well. Therefore we used a primary human osteoblast model to examine whether 25(OH)D3 itself can affect osteoblast function using CYP27B1 silencing and to investigate whether 24R,25(OH)2D3 can affect osteoblast function. We showed that primary human osteoblasts responded to both 25(OH)D3 and 1,25(OH)2D3 by reducing their proliferation and enhancing their differentiation by the increase of alkaline phosphatase, osteocalcin and osteopontin expression. Osteoblasts expressed CYP27B1 and CYP24 and synthesized 1,25(OH)2D3 and 24R,25(OH)2D3 dose-dependently. Silencing of CYP27B1 resulted in a decline of 1,25(OH)2D3 synthesis, but we observed no significant differences in mRNA levels of differentiation markers in CYP27B1-silenced cells compared to control cells after treatment with 25(OH)D3. We demonstrated that 24R,25(OH)2D3 increased mRNA levels of alkaline phosphatase, osteocalcin and osteopontin. In addition, 24R,25(OH)2D3 strongly increased CYP24 mRNA. In conclusion, the vitamin D metabolites 25(OH)D3, 1,25(OH)2D3 and 24R,25(OH)2D3 can affect osteoblast differentiation directly or indirectly. We showed that primary human osteoblasts not only respond to 1,25(OH)2D3, but also to 24R,25(OH)2D3 by enhancing osteoblast differentiation. This suggests that 25(OH)D3 can affect osteoblast differentiation via conversion to the active metabolite 1,25(OH)2D3, but also via conversion to 24R,25(OH)2D3. Whether 25(OH)D3 has direct actions on osteoblast function needs further investigation.
机译:生物活性最高的代谢物1,25-二羟基维生素D3(1,25(OH)2D3)对体外成骨细胞的生长和分化具有直接的直接影响。前体25-羟基维生素D3(25(OH)D3)可以通过转化为1,25(OH)2D3来影响成骨细胞的功能,但是,很大程度上未知25(OH)D3是否可以单独影响成骨细胞的主要功能。此外,25(OH)D3不仅转化为1,25(OH)2D3,而且还转化为也具有生物活性的24R,25-二羟基维生素D3(24R,25(OH)2D3)。因此,我们使用主要的人类成骨细胞模型使用CYP27B1沉默来检查25(OH)D3本身是否会影响成骨细胞功能,并研究24R,25(OH)2D 3 是否会影响成骨细胞功能。我们显示人类原代成骨细胞通过减少增殖来对25(OH)D 3 和1,25(OH) 2 D 3 做出反应通过增加碱性磷酸酶,骨钙素和骨桥蛋白的表达来增强它们的分化。成骨细胞表达CYP27B1和CYP24并合成1,25(OH) 2 D 3 和24R,25(OH) 2 D 3 取决于剂量。 CYP27B1沉默导致1,25(OH) 2 D 3 合成减少,但我们观察到CYP27B1沉默的细胞中分化标志物的mRNA水平没有显着差异与25(OH)D 3 处理后的对照细胞相比。我们证明了24R,25(OH) 2 D 3 增加了碱性磷酸酶,骨钙素和骨桥蛋白的mRNA水平。此外,24R,25(OH) 2 D 3 强烈增加CYP24 mRNA的表达。总之,维生素D代谢产物25(OH)D 3 ,1,25(OH) 2 D 3 和24R,25(OH) ) 2 D 3 可以直接或间接影响成骨细胞的分化。我们发现人类原代成骨细胞不仅对1,25(OH) 2 D 3 有反应,而且对24R,25(OH) 2 有反应> D 3 通过增强成骨细胞分化。这表明25(OH)D 3 可以通过转化为活性代谢物1,25(OH) 2 D 3 影响成骨细胞的分化,而且还可以转换为24R,25(OH) 2 D 3 。 25(OH)D 3 是否对成骨细胞功能有直接作用需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号